| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |